Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: Optum rx - You Need To See This

Forced to sell medications at a loss, rural Texas pharmacies seek new survival tactics

Independent rural pharmacists are starting other businesses or selling baby shower gifts to keep their stores operating. Pharmacy deserts affect 4 million Texans.

The Texas Tribune

Is This Defensive Giant a Good Stock to Buy in a Volatile Market?

Defensive blue-chip stock UnitedHealth is on a credible path back to double-digit growth next year, but is UNH a buy right now?

Barchart

After a 29% Slide YTD, Is UnitedHealth Stock Poised for a Rebound?

While UnitedHealth's scale remains unmatched, scale alone is not enough. Its future rests on restoring profitability.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Cracker Barrel, MongoDB, Okta, UnitedHealth And Nvidia: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed higher on Tuesday, with the Dow Jones Industrial Average rising 0.3% to 45,418.07. The SP 500 added 0.4% to 6,465.94, while the Nasdaq matched the gain, finishing at 21,544.27.These are the top stocks that gained the attention of retail traders and investors through the day: Cracker Barrel…

Benzinga

UnitedHealth Stock Falls As Department Of Justice Criminal Probe Expands To Optum Rx: Report

UnitedHealth Group Inc (NYSE:UNH) shares closed Tuesday’s session lower following a Bloomberg report suggesting a U.S. Department of Justice criminal probe into the company is broader than previously known, according to people familiar with the matter.

Benzinga

UnitedHealth Stock Just Raised Its Dividend. Should You Buy UNH Now?

UnitedHealth Group has raised its dividend by 5.2% to $2.21 per share, marking 15 years of consecutive increases.

Barchart

Wisconsin Man Died of Asthma Attack Days After Inhaler Prices Skyrocketed Without Warning. Now His Family Is Suing His Insurer

A 22-year-old Wisconsin man died from an asthma attack days after he couldn't pay for his inhaler due to an unexpected price increase—Now his parents are suing.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

Couple sues Walgreens and Optum Rx over son’s death after $500 price rise for asthma meds

A Wisconsin couple is suing Walgreens and a pharmacy benefits company alleging their son died because he couldn't afford a sudden $500 jump in the cost of his asthma medication

The Independent UK

James Comer gives major pharmacy benefit managers hard deadline to change 'materially false' statements

Comer claims statements about them not steering patients to PBM-owned pharmacies are false and reminds witnesses that lying under oath can send them to prison

Latin Times

Cheaper competition for Humira is hitting the market, but savings will depend on your insurance

Patients who take the autoimmune disease treatment Humira may see some price relief when several lower-cost, biosimilar versions of the AbbVie drug reach the U.S. market in July

The Independent UK

CVS cuts lead to patient panic

Many of the patients left in the lurch have life-threatening digestive disorders that render them unable to eat or

Salon

Decisions by CVS and Optum panicked thousands of their sickest patients

NEW YORK — The fear started when a few patients saw their nurses and dietitians posting job searches on LinkedIn.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Ohio State University

122 stories

MDB

99 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.